These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9570545)

  • 21. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
    Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
    J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Liu X; Hu J; Zhang X; Fan D
    Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P
    J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The involvement of tumor necrosis factor in immunity to Salmonella infection.
    Tite JP; Dougan G; Chatfield SN
    J Immunol; 1991 Nov; 147(9):3161-4. PubMed ID: 1919009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral mixed DNA vaccine protects mice from infection of Toxoplasma gondii].
    Cong H; Gu QM; Zhou HY; Guo L; Yang TT; He SY; Li Y; Zhao QL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):159-62. PubMed ID: 16300008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
    Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
    Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The roles of Nramp1 and Tnfa genes in nitric oxide production and their effect on the growth of Salmonella typhimurium in macrophages from Nramp1 congenic and tumor necrosis factor-alpha-/- mice.
    Ables GP; Takamatsu D; Noma H; El-Shazly S; Jin HK; Taniguchi T; Sekikawa K; Watanabe T
    J Interferon Cytokine Res; 2001 Jan; 21(1):53-62. PubMed ID: 11177581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.
    Satoskar AR; Bozza M; Rodriguez Sosa M; Lin G; David JR
    Infect Immun; 2001 Feb; 69(2):906-11. PubMed ID: 11159984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters.
    McSorley SJ; Xu D; Liew FY
    Infect Immun; 1997 Jan; 65(1):171-8. PubMed ID: 8975908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
    Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
    Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenicity of attenuated Salmonella choleraesuis vaccine strain expressing immunogenic genes of Mycoplasma hyopneumoniae in mice].
    Ma F; Zou H; He Q
    Wei Sheng Wu Xue Bao; 2011 Sep; 51(9):1270-7. PubMed ID: 22126084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG.
    Hess J; Grode L; Hellwig J; Conradt P; Gentschev I; Goebel W; Ladel C; Kaufmann SH
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):283-9. PubMed ID: 10727883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor survival but high immunogenicity of IL-2-expressing Salmonella typhimurium in inherently resistant mice.
    al-Ramadi BK; Bashir G; Rizvi TA; Fernandez-Cabezudo MJ
    Microbes Infect; 2004 Apr; 6(4):350-9. PubMed ID: 15050962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.
    Chakour R; Guler R; Bugnon M; Allenbach C; Garcia I; Mauël J; Louis J; Tacchini-Cottier F
    Infect Immun; 2003 Sep; 71(9):5287-95. PubMed ID: 12933876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice.
    Kremer IB; Gould MP; Cooper KD; Heinzel FP
    Infect Immun; 2001 Feb; 69(2):673-80. PubMed ID: 11159954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of innate immune responses by IL-2-expressing Salmonella typhimurium is independent of Toll-like receptor 4.
    al-Ramadi BK; Fernandez-Cabezudo MJ; Mustafa N; Xu D
    Mol Immunol; 2004 Jan; 40(10):671-9. PubMed ID: 14644093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.